Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025

Rhea-AI Summary

Haemonetics (NYSE: HAE) has announced it will release its third quarter fiscal year 2025 financial results on Thursday, February 6, 2025 at 6:00 am ET. The company will host a conference call with investors and analysts at 8:00 am ET on the same day to discuss the results and address questions.

Participants can access the call via teleconference after completing registration, and are encouraged to join 10 minutes before the start. A live webcast will be available on Haemonetics' investor relations website, with both the conference call and webcast replay accessible for one year starting February 6, 2025, at 11:00 am ET.

BOSTON, Jan. 8, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2025 financial results at 6:00 am ET on Thursday, February 6, 2025. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on February 6, 2025.

The call can be accessed via teleconference at: Q3 2025 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/63jte4ra 

A replay of the conference call and webcast will be available for one year beginning on February 6, 2025 at 11:00 am ET using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury		David Trenk, Manager-Investor Relations
(781) 356-9763		(203) 733-4987
olga.guyette@haemonetics.com		david.trenk@haemonetics.com
Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-third-quarter-fiscal-year-2025-results-february-6-2025-302346400.html

SOURCE Haemonetics Corporation

FAQ

When will Haemonetics (HAE) release Q3 2025 earnings?

Haemonetics will release its Q3 fiscal year 2025 earnings on Thursday, February 6, 2025, at 6:00 am ET.

What time is Haemonetics (HAE) Q3 2025 earnings call?

Haemonetics' Q3 2025 earnings conference call is scheduled for 8:00 am ET on February 6, 2025.

How long will HAE's Q3 2025 earnings call replay be available?

The replay of Haemonetics' Q3 2025 earnings call and webcast will be available for one year, beginning February 6, 2025, at 11:00 am ET.

How can investors access Haemonetics (HAE) Q3 2025 earnings call?

Investors can access the call via teleconference after registration or through a live webcast on Haemonetics' investor relations website.